EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Reduction of H3K9 methylation by G9a inhibitors improves the development of mouse SCNT embryos

Shogo Matoba, Daiki Shikata, Fumiyuki Shirai, Takaki Tatebe, Michiko Hirose, Akiko Nakata, Naomi Watanabe, Ayumi Hasegawa, Akihiro Ito, Minoru Yoshida, Atsuo Ogura

Stem Cell Reports · 2024-06 · 19 (6) · 906-921

DOI: 10.1016/j.stemcr.2024.04.003 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Stem Cell Reports, 2024-06. Verfasst von Shogo Matoba und 10 weiteren Autor:innen. Beteiligte Einrichtung: Bioresource Engineering Division, Bioresource Research Center, RIKEN, Tsukuba, Ibaraki 305-0074, Japan; Cooperative Division of Veterinary Sciences, …. Hauptthemen laut MEDLINE: Histones, Nuclear Transfer Techniques, Histone-Lysine N-Methyltransferase. Die Arbeit wurde bisher 22-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Japan Agency for Medical Research and Development, Japan Science and Technology Agency.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Removal of somatic histone H3 lysine 9 trimethylation (H3K9me3) from the embryonic genome can improve the efficiency of mammalian cloning using somatic cell nuclear transfer (SCNT). However, this strategy involves the injection of histone demethylase mRNA into embryos, which is limiting because of its invasive and labor-consuming nature. Here, we report that treatment with an inhibitor of G9a (G9ai), the major histone methyltransferase that introduces H3K9me1/2 in mammals, greatly improved the development of mouse SCNT embryos. Intriguingly, G9ai caused an immediate reduction of H3K9me1/2, a secondary loss of H3K9me3 in SCNT embryos, and increased the birth rate of cloned pups about 5-fold (up to 3.9%). G9ai combined with the histone deacetylase inhibitor trichostatin A further improved this rate to 14.5%. Mechanistically, G9ai and TSA synergistically enhanced H3K9me3 demethylation and boosted zygotic genome activation. Thus, we established an easy, highly effective SCNT protocol that would enhance future cloning research and applications.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HistonesNuclear Transfer TechniquesHistone-Lysine N-MethyltransferaseAnimalsMiceMethylationCloning, OrganismEmbryo, MammalianEmbryonic DevelopmentHydroxamic AcidsFemaleHistone Deacetylase Inhibitors

Stichwörter der Autor:innen

G9aH3K9 methylationH3K9me3Kdm3aRK-701Somatic cell nuclear transfercloninginhibitormousetrichostatin A

Substanzen

HistonesHistone-Lysine N-MethyltransferaseG9a protein, mousetrichostatin AHydroxamic AcidsHistone Deacetylase Inhibitors

Autor:innen und Institutionen

  • Bioresource Engineering Division, Bioresource Research Center, RIKEN, Tsukuba, Ibaraki 305-0074, Japan; Cooperative Division of Veterinary Sciences, Tokyo University of Agriculture and Technology, Fuchu, Tokyo 183-8509,…
  • Bioresource Engineering Division, Bioresource Research Center, RIKEN, Tsukuba, Ibaraki 305-0074, Japan; Graduate School of Life and Environmental Sciences, University of Tsukuba, Tsukuba, Ibaraki 305-8572, Japan.
  • Drug Discovery Chemistry Platform Unit, RIKEN Center for Sustainable Resource Science, Wako, Saitama 351-0198, Japan.
  • Bioresource Engineering Division, Bioresource Research Center, RIKEN, Tsukuba, Ibaraki 305-0074, Japan.
  • Drug Discovery Seed Compounds Exploratory Unit, RIKEN Center for Sustainable Resource Science, Wako, Saitama 351-0198, Japan.
  • Laboratory of Cell Signaling, School of Life Sciences, Tokyo University of Pharmacy and Life Sciences, Hachioji, Tokyo 192-0392, Japan; Chemical Genomics Research Group, RIKEN Center for Sustainable Resource Science, Wa…

Förderung

  • Japan Society for the Promotion of Science
  • Japan Agency for Medical Research and Development
  • Japan Science and Technology Agency

Zitieren

APA

Matoba, S., Shikata, D., Shirai, F., Tatebe, T., Hirose, M., Nakata, A., Watanabe, N., Hasegawa, A., Ito, A., Yoshida, M., & Ogura, A. (2024). Reduction of H3K9 methylation by G9a inhibitors improves the development of mouse SCNT embryos. Stem Cell Reports, 19(6), 906-921. https://doi.org/10.1016/j.stemcr.2024.04.003

Vancouver

Matoba S, Shikata D, Shirai F, Tatebe T, Hirose M, Nakata A, et al. Reduction of H3K9 methylation by G9a inhibitors improves the development of mouse SCNT embryos. Stem Cell Reports. 2024;19(6):906-921. doi:10.1016/j.stemcr.2024.04.003

BibTeX
@article{Matoba2024,
  author = {Matoba, Shogo and Shikata, Daiki and Shirai, Fumiyuki and Tatebe, Takaki and Hirose, Michiko and Nakata, Akiko and Watanabe, Naomi and Hasegawa, Ayumi and Ito, Akihiro and Yoshida, Minoru and Ogura, Atsuo},
  title = {Reduction of H3K9 methylation by G9a inhibitors improves the development of mouse SCNT embryos},
  journal = {Stem Cell Reports},
  year = {2024},
  volume = {19},
  number = {6},
  pages = {906--921},
  doi = {10.1016/j.stemcr.2024.04.003}
}
Kostenlos starten →